Abdalla Marwah, Booth John N, Seals Samantha R, Spruill Tanya M, Viera Anthony J, Diaz Keith M, Sims Mario, Muntner Paul, Shimbo Daichi
From the Department of Medicine, Columbia University Medical Center, New York, NY (M.A., K.M.D., D.S.); Department of Epidemiology, University of Alabama at Birmingham (J.N.B., P.M.); Center of Biostatistics and Bioinformatics, Department of Preventive Medicine (S.R.S.) and Department of Medicine (M.S.), University of Mississippi Medical Center, Jackson; Department of Population Health, NYU School of Medicine, NY (T.M.S.); and Hypertension Research Program, Department of Family Medicine, University of North Carolina at Chapel Hill (A.J.V.).
Hypertension. 2016 Jul;68(1):220-6. doi: 10.1161/HYPERTENSIONAHA.115.06904. Epub 2016 May 16.
Masked hypertension, defined as nonelevated clinic blood pressure (BP) and elevated out-of-clinic BP may be an intermediary stage in the progression from normotension to hypertension. We examined the associations of out-of-clinic BP and masked hypertension using ambulatory BP monitoring with incident clinic hypertension in the Jackson Heart Study, a prospective cohort of blacks. Analyses included 317 participants with clinic BP <140/90 mm Hg, complete ambulatory BP monitoring, who were not taking antihypertensive medication at baseline in 2000 to 2004. Masked daytime hypertension was defined as mean daytime blood pressure ≥135/85 mm Hg, masked night-time hypertension as mean night-time BP ≥120/70 mm Hg, and masked 24-hour hypertension as mean 24-hour BP ≥130/80 mm Hg. Incident clinic hypertension, assessed at study visits in 2005 to 2008 and 2009 to 2012, was defined as the first visit with clinic systolic/diastolic BP ≥140/90 mm Hg or antihypertensive medication use. During a median follow-up of 8.1 years, there were 187 (59.0%) incident cases of clinic hypertension. Clinic hypertension developed in 79.2% and 42.2% of participants with and without any masked hypertension, 85.7% and 50.4% with and without masked daytime hypertension, 79.9% and 43.7% with and without masked night-time hypertension, and 85.7% and 48.2% with and without masked 24-hour hypertension, respectively. Multivariable-adjusted hazard ratios (95% confidence interval) of incident clinic hypertension for any masked hypertension and masked daytime, night-time, and 24-hour hypertension were 2.13 (1.51-3.02), 1.79 (1.24-2.60), 2.22 (1.58-3.12), and 1.91 (1.32-2.75), respectively. These findings suggest that ambulatory BP monitoring can identify blacks at increased risk for developing clinic hypertension.
隐匿性高血压定义为诊室血压正常但诊室外血压升高,它可能是从正常血压进展到高血压的中间阶段。在杰克逊心脏研究(一项针对黑人的前瞻性队列研究)中,我们使用动态血压监测来研究诊室外血压及隐匿性高血压与新发诊室高血压之间的关联。分析纳入了317名诊室血压<140/90 mmHg、动态血压监测完整且在2000年至2004年基线时未服用抗高血压药物的参与者。隐匿性日间高血压定义为日间平均血压≥135/85 mmHg,隐匿性夜间高血压定义为夜间平均血压≥120/70 mmHg,隐匿性24小时高血压定义为24小时平均血压≥130/80 mmHg。在2005年至2008年以及2009年至2012年的研究访视中评估的新发诊室高血压定义为首次出现诊室收缩压/舒张压≥140/90 mmHg或使用抗高血压药物。在中位随访8.1年期间,有187例(59.0%)新发诊室高血压病例。有和没有任何隐匿性高血压的参与者中,诊室高血压的发生率分别为79.2%和42.2%;有和没有隐匿性日间高血压的参与者中,发生率分别为85.7%和50.4%;有和没有隐匿性夜间高血压的参与者中,发生率分别为79.9%和43.7%;有和没有隐匿性24小时高血压的参与者中,发生率分别为85.7%和48.2%。任何隐匿性高血压、隐匿性日间高血压、隐匿性夜间高血压和隐匿性24小时高血压发生诊室高血压的多变量调整风险比(95%置信区间)分别为2.13(1.51 - 3.02)、1.79(1.24 - 2.60)、2.22(1.58 - 3.12)和1.91(1.32 - 2.75)。这些发现表明,动态血压监测可以识别出发生诊室高血压风险增加的黑人。